Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit
By Meghan Kelly · December 15, 2020, 5:46 PM EST
Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...
The Centers for Medicare and Medicaid Services recently finalized highly anticipated guidance providing a new pathway for Medicare cov... (more story)